Health Care Sector Update for 09/05/2018: HSGX, PRQR, NVS, AGIO, PFE

Shutterstock photo

Top Health Care Stocks:

JNJ: flat

PFE: flat

ABT: flat

MRK: flat

AMGN: -0.3%

Health care shares were mostly flat ahead of the bell on Wednesday.

Expected movers:

- Histogenics ( HSGX ) said its phase 3 trial of NeoCart failed to meet the primary endpoint

- ProQR Therapeutics ( PRQR ) received positive results from a planned interim analysis of its phase 1/2 trial of QR-110 in patients with Leber's congenital amaurosis 10

- Novartis ( NVS ) was selected by NHS England to provide its CAR-T therapy to children and young people under the age of 25 who have B cell acute lymphoblastic leukemia

Other news:

- Agios Pharmaceuticals ( AGIO ) named Jacqualyn Fouse as the company's next CEO, succeeding David Schenkein

- Pfizer ( PFE ) unveiled the pricing of a $5 billion debt offering, which consists of six tranches of notes

News from overseas:

- Primary Health Properties PLC (PHP.LN) said that the value of its Irish portfolio increased to EUR100.0 million after it acquired three further care centres in Ireland

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Copyright (C) 2016 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.

This article appears in: Investing , US Markets
Referenced Symbols: HSGX , PRQR , NVS , AGIO , PFE

More from MT Newswires


MT Newswires

MT Newswires

Market News, Commodities

Research Brokers before you trade

Want to trade FX?